Llwytho...
Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics
Cinacalcet, a type II calcimimetic agent that interacts with the calcium-sensing receptor on the parathyroid gland and increases its sensitivity to calcium, has proved an effective therapy for the treatment of the biochemical derangements that comprise uraemic secondary hyperparathyroidism. These pa...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | NDT Plus |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2008
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4421154/ https://ncbi.nlm.nih.gov/pubmed/25983954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfm042 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|